Peptide record

TPDB05062

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
20 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05062
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 iACP-DRLF Antifungipept CAFPdb APD_complete APD_hemolytic HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 20-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FLPIIAGMAAKVICAITKKC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C96H167N23O22S3
RNDEQHSWY
AI
2091.70
9.80
3
0
12
+3
-1.27
1.425
132.00
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
125
0.06
3
Residue Composition
number
4
A
0
R
0
N
0
D
2
C
0
E
0
Q
1
G
0
H
4
I
1
L
3
K
1
M
1
F
1
P
0
S
1
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 4 R: 0 N: 0 D: 0 C: 2 E: 0 Q: 0 G: 1 H: 0 I: 4 L: 1 K: 3 M: 1 F: 1 P: 1 S: 0 T: 1 W: 0 Y: 0 V: 1
Chemical Descriptors
20 reviewed residue count
C96H167N23O22S3 sequence-only estimate (linear, free termini)
2091.70 sequence-only estimate (linear, free termini)
9.80 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
-1.27 sequence-only estimate (linear, free termini)
1.425 sequence-only estimate (linear, free termini)
Evidence Records 16 records
Evidence 1 Activity

Activity

MIC
Antibacterial
50 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Activity against E. coli (MIC 50 uM), S. aureus (MIC 6 uM), and C. albicans (MIC 13 uM). Updated 5/2018.
Evidence 2 Activity

Activity

MIC
Antibacterial
6 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

Activity against E. coli (MIC 50 uM), S. aureus (MIC 6 uM), and C. albicans (MIC 13 uM). Updated 5/2018.
Evidence 3 Activity

Activity

MIC
Antibacterial
13 µM

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

Activity against E. coli (MIC 50 uM), S. aureus (MIC 6 uM), and C. albicans (MIC 13 uM). Updated 5/2018.
Evidence 4 Activity

Activity

MIC
Antifungal
50 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Activity against E. coli (MIC 50 uM), S. aureus (MIC 6 uM), and C. albicans (MIC 13 uM). Updated 5/2018.
Evidence 5 Activity

Activity

MIC
Antifungal
6 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Activity against E. coli (MIC 50 uM), S. aureus (MIC 6 uM), and C. albicans (MIC 13 uM). Updated 5/2018.
Evidence 6 Activity

Activity

MIC
Antifungal
13 µM

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Activity against E. coli (MIC 50 uM), S. aureus (MIC 6 uM), and C. albicans (MIC 13 uM). Updated 5/2018.
Evidence 7 Activity

Activity

MIC
Antiparasitic
50 µM

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Activity against E. coli (MIC 50 uM), S. aureus (MIC 6 uM), and C. albicans (MIC 13 uM). Updated 5/2018.
Evidence 8 Activity

Activity

MIC
Antiparasitic
6 µM

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

Activity against E. coli (MIC 50 uM), S. aureus (MIC 6 uM), and C. albicans (MIC 13 uM). Updated 5/2018.
Evidence 9 Activity

Activity

MIC
Antiparasitic
13 µM

Target

Candida albicans

Source & Reference

DRAMP

Other

Activity against E. coli (MIC 50 uM), S. aureus (MIC 6 uM), and C. albicans (MIC 13 uM). Updated 5/2018.
Evidence 10 Activity

Activity

MIC
Antiviral
50 µM

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Activity against E. coli (MIC 50 uM), S. aureus (MIC 6 uM), and C. albicans (MIC 13 uM). Updated 5/2018.
Evidence 11 Activity

Activity

MIC
Antiviral
6 µM

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

Activity against E. coli (MIC 50 uM), S. aureus (MIC 6 uM), and C. albicans (MIC 13 uM). Updated 5/2018.
Evidence 12 Activity

Activity

MIC
Antiviral
13 µM

Target

Candida albicans

Source & Reference

DRAMP

Other

Activity against E. coli (MIC 50 uM), S. aureus (MIC 6 uM), and C. albicans (MIC 13 uM). Updated 5/2018.
Evidence 13 Activity

Activity

HC50
Hemolysis
25 µM
[Ref.15556063]HC50=25 µM against human erythrocytes

Target

human erythrocytes

Source & Reference

Hemolytik APD_complete APD_hemolytic PD_Hemolysis
DRAMP4
Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct 139(1-3):31-38.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 14 Activity

Activity

50% Hemolysis
Toxicity
25 µM
Hemolytic Cytotoxic
50% Hemolysis | 25 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis). | Comp Biochem Physiol C Toxicol Pharmacol | 2004
Evidence 15 Activity

Activity

HC50
Toxicity
25 µM
Hemolytic
Hemolytic_activity: [Ref.15556063]HC50=25 µM against human erythrocytes

Target

erythrocytes

Source & Reference

NA
DRAMP
Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct 139(1-3):31-38.
Evidence 16 Hemolysis

Activity

25 µM
HC50
[Ref.15556063]HC50=25 µM against human erythrocytes
Hemolysis

Target

human erythrocytes

Source & Reference

APD_complete APD_hemolytic HemoPI PD_Hemolysis
Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct 139(1-3):31-38.
DRAMP4
APD_complete APD_hemolytic PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation.